Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582868 · ClinicalTrials.gov registry record
Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00582868: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT00582868 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582868 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.
Interventions
- DEVICE Licox Brain Oxygen Monitor
- OTHER CSF
- OTHER Whole blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-05 |
Why NCT00582868 stopped before completion
NCT00582868 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Licox Brain Oxygen Monitor is the first listed.
NCT00582868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582868 about?
NCT00582868 is a clinical study titled "Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH". The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.
What is the current status of trial NCT00582868?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2007-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00582868?
The interventions under investigation include: Licox Brain Oxygen Monitor (DEVICE), CSF (OTHER), Whole blood (OTHER).
Who is sponsoring clinical trial NCT00582868?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia